|

Enfortumab vedotin-ejfv (EV) Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Padcev

Pipeline

Phase 1/2: 1

Top Sponsors

  • Dana-Farber Cancer Institute1

Indications

  • Bladder Cancer1
  • Metastatic Urothelial Carcinoma of the Renal Pelvis and Ureter1
  • Metastatic Urothelial Carcinoma1
  • Urothelial Cancer1
  • Cancer1

Boston, Massachusetts1 trial

Sacituzumab Govitecan Plus EV in Metastatic UC

Dana Farber Cancer Institute

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.